Evaluation Incidence of Ocular Complications of Hydroxychloroquine and Related Risk Factors in Patients with Connective Tissue Disease Referred to the Rheumatology Clinic of Tohid Hospital in Sanandaj
Background and Aim: Hydroxychloroquine is used to treat many rheumatic diseases. This drug has been widely used, especially in the treatment of rheumatoid arthritis and lupus. One of the most important side effects of these drugs is retinopathy and changes in the visual field. This study aimed to de...
Main Authors: | Nasrin Moghimi, Ezzat Rahimi, Jamil Eslamipour, Naser Reshadmanesh, Afshin Saeidi |
---|---|
Format: | Article |
Language: | fas |
Published: |
Kurdistan University of Medical Sciences
2023-03-01
|
Series: | مجله علمی دانشگاه علوم پزشکی کردستان |
Subjects: | |
Online Access: | http://sjku.muk.ac.ir/article-1-6351-en.html |
Similar Items
-
A study to determine the effect of hydroxychloroquine (HCQ) on central corneal thickness (CCT) in patients with rheumatoid arthritis (RA)
by: Roshan Christina Jaichander, et al.
Published: (2024-01-01) -
Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
by: Elizabeth Park, et al.
Published: (2021-10-01) -
Combined disease modifying treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine
by: N A Sergiets, et al.
Published: (2009-02-01) -
Evaluation of the effects of Hydroxychloroquine on macular central visual function by multifocal electroretinogram
by: Hong Jiang, et al.
Published: (2021-03-01) -
Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician–Patient Communication
by: Amal Aldarwesh, et al.
Published: (2022-11-01)